XML 22 R13.htm IDEA: XBRL DOCUMENT

Warrants	9 Months Ended
Sep. 30, 2023
Warrants and Rights Note Disclosure [Abstract]
Warrants	7. Warrants On June 14, 2017, the Company entered into a securities purchase agreement with certain accredited investors (the “Purchasers”) pursuant to which the Company sold an aggregate of 3,749,783 shares (the “Shares”) of its common stock and warrants to purchase up to an aggregate of 2,812,337 shares of its common stock to the Purchasers (the “Warrants”). The combined purchase price for one Share and one Warrant to purchase 0.75 shares of common stock was $1.15. The closing of the issuance of the Shares and the Warrants occurred on June 19, 2017. The Warrants had an exercise price of $1.30 per share, subject to adjustment as provided therein, and became exercisable beginning on December 19, 2017 through December 19, 2022. During the year ended December 31, 2022, 487,087 Warrants were exercised. The Warrants were exercised in full during the year ended December 31, 2022.

Warrants

9 Months Ended

Sep. 30, 2023

Warrants and Rights Note Disclosure [Abstract]

7. Warrants

On June 14, 2017, the Company entered into a securities purchase agreement with certain accredited investors (the “Purchasers”) pursuant to which the Company sold an aggregate of 3,749,783 shares (the “Shares”) of its common stock and warrants to purchase up to an aggregate of 2,812,337 shares of its common stock to the Purchasers (the “Warrants”). The combined purchase price for one Share and one Warrant to purchase 0.75 shares of common stock was $1.15. The closing of the issuance of the Shares and the Warrants occurred on June 19, 2017. The Warrants had an exercise price of $1.30 per share, subject to adjustment as provided therein, and became exercisable beginning on December 19, 2017 through December 19, 2022. During the year ended December 31, 2022, 487,087 Warrants were exercised. The Warrants were exercised in full during the year ended December 31, 2022.